Sleep Disturbances and Delirium
About the study
Delirium is a frequent and serious problem in hospitalized patients; it is associated with multiple hospital-acquired complications. There is evidence that the incidence of deliri-um may be minimized by multimodal interventions (pain management, shortening the duration of mechanical ventilation, light sedation, avoiding benzodiazepines, routine delirium monitoring, and early mobilization). Even though a clear association between sleep and delirium has not been established, many studies suggest that sleep disturban-ces may be a key risk factor for the development of delirium. Therefore, sleep promoti-on is becoming an integral part of clinical care. The project support the hypothesis that non-pharmacological preventive interventions promoting sleep (sleep protocol) positive-ly influence the quality of sleep and reduce the incidence of delirium in hospitalized patients. This will be verified by qualitative and quantitative research methods, with the quantitative study being divided into three prospective cross-sectional studies and one interventional study. Data will be obtained from 3240 hospitalized patients by combi-ning subjective methods (questionnaire surveys) and objective measurements (acti-graphy). The project outcomes will allow better understanding of the relationship betwe-en sleep and delirium. A set of non-pharmacological preventive interventions promoting sleep will be developed, with a subsidiary aim to potentially reduce the incidence of delirium in hospitalized patients.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- age over 18 years
- a hospital stay longer than 24 hours
- a hospital stay longer than 36 hours
- hospitalized for at least 72 hours, without previous sleep disturbances, without cognitive impairment
EXCLUSION CRITERIA
Exclusion Criteria:
- Patients with cognitive impairment preventing them from cooperating
- Glasgow Coma Scale score below 12
- terminal disease
- previous and current treatment for sleep disturbances
- neurocognitive dysfunction (dementia)
- sedative administration over the last 24 hours
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study Details
Contition
Sleep Disturbance
Age
18+
Phase
NA
Participants Needed
3240
Est. Completion Date
Dec 31, 2025
Treatment Type
INTERVENTIONAL
Sponsor
University of Ostrava
ClinicalTrials.gov NCT Identifier
NCT05402280
Study Number
SLEEP
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?